Checo J. Rorie, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Toxicology, Oncology, Molecular Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Godfrey S, Rorie C. Abstract A08: Cadmium elicits a differential cytotoxic response in triple-negative breast cancer cells Cancer Prevention Research. 13. DOI: 10.1158/1940-6215.Envcaprev19-A08  0.479
2020 Godfrey S, Rorie C. Abstract B072: Cadmium elicits a differential cytotoxic response in triple-negative breast cancer cells Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B072  0.443
2017 Rorie CJ, Moses MM, Musa MK, Godfrey SS. Abstract 5879: Establishing doxorubicin resistant HCC1806 triple negative breast cancer cell lines result in the differential expression of let7a and miR34a Cancer Research. 77: 5879-5879. DOI: 10.1158/1538-7445.Am2017-5879  0.505
2016 Baines AT, Martin PM, Rorie CJ. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer. Progress in Molecular Biology and Translational Science. 144: 277-320. PMID 27865460 DOI: 10.1016/Bs.Pmbts.2016.09.006  0.33
2016 Moses MM, Godfrey SS, Lusk NQ, Rorie CJ. Abstract 83: MicroRNAs associated with the p53 tumor suppressor signaling network are differentially expressed in triple negative breast cancer cell lines Cancer Research. 76: 83-83. DOI: 10.1158/1538-7445.Am2016-83  0.497
2014 Rorie CJ, Arrington BL, Godfrey SS, McCoy AS, Gurley KM. Abstract 1472: The differential expression of miRNAs in breast cancer cell lines Cancer Research. 74: 1472-1472. DOI: 10.1158/1538-7445.Am2014-1472  0.47
2013 Rorie CJ, Richardson SL, Lucas AC, Thomas PA, Gurley KM, Franks MA. Abstract 604: Styrene compounds induce apoptosis in triple negative breast cancer cell lines. Cancer Research. 73: 604-604. DOI: 10.1158/1538-7445.Am2013-604  0.476
2012 Rorie CJ, King J, Bryant R, Gurley K. Abstract 4908: The apoptotic response of the triple negative breast cancer cell line HCC1806 to chemotherapeutics Cancer Research. 72: 4908-4908. DOI: 10.1158/1538-7445.Am2012-4908  0.52
2011 King JL, Gurley KM, Rorie CJ. Abstract 2141: The differential apoptotic responses of normal breast cells versus luminal and triple negative breast cancer cells to chemotherapeutic agents Cancer Research. 71: 2141-2141. DOI: 10.1158/1538-7445.Am2011-2141  0.523
2006 Saxena A, Rorie CJ, Dimitrova D, Daniely Y, Borowiec JA. Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene. 25: 7274-88. PMID 16751805 DOI: 10.1038/Sj.Onc.1209714  0.394
2004 Rorie CJ, Weissman BE. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Cancer Research. 64: 7288-95. PMID 15492248 DOI: 10.1158/0008-5472.Can-04-1610  0.628
2004 Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Research. 64: 1266-77. PMID 14973077 DOI: 10.1158/0008-5472.Can-03-3274  0.508
2001 Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. Journal of Cellular Physiology. 186: 136-45. PMID 11147808 DOI: 10.1002/1097-4652(200101)186:1<136::Aid-Jcp1010>3.0.Co;2-4  0.615
Show low-probability matches.